Stock 002644 LANZHOU FOCI PHARMACEUTICAL CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company LanZhou Foci Pharmaceutical Co.,Ltd.

Equities

002644

CNE1000019W4

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 05/05/2024 BST 		5-day change 1st Jan Change
7.9 CNY +1.54% Intraday chart for LanZhou Foci Pharmaceutical Co.,Ltd. +6.61% -18.97%
04-10 Lanzhou Foci Pharmaceutical Chairman Resigns MT
04-09 LanZhou Foci Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

LanZhou Foci Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs and large health products. The Company’s main products are categorized into pills, tablets, granules, syrups, capsules, glue and others, including Liuwei Dihuang pills, Xiaoyao Pill, Xiangsha Yangwei pills, ginseng Gubeng Huanhao pills and other Chinese patent drugs, as well as large health products, such as Ejiao and Ejiao loafs. The Company distributes its products under the brand names Foci, Baolu and Mianshan. The Company is also involved in the cultivation, processing and marketing of Chinese herbal medicine. The Company distributes its products in domestic market and to overseas markets.

Number of employees: 1,353

Sales per Business

CNY in Million2022Weight2023Weight Delta
Traditional Chinese Medicine, Chinese Medicinal Materials and Protective Equipment
99.3 %
985 96.6 % 1,155 99.3 % +17.27%
Other
0.5 %
- - 5 0.5 % -
Food and Health Products
0.2 %
3 0.3 % 2 0.2 % -40.83%
Pharmaceutical Packaging Materials
0.1 %
1 0.1 % 1 0.1 % +15.48%
Nucleic Acid Testing Service
0.0 %
31 3.0 % 0 0.0 % -99.69%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
91.1 %
942 92.4 % 1,059 91.1 % +12.49%
Abroad
8.9 %
77 7.6 % 104 8.9 % +33.95%

Managers

Managers TitleAgeSince
Ai Guo Shi CEO
 Chief Executive Officer 60 29/06/17
Jin feng Yue DFI
 Director of Finance/CFO - 01/12/22
Li Jun Wu BRD
 Director/Board Member 50 31/10/91
Ying Chun Wang BRD
 Director/Board Member 47 01/01/20
Wen Ting An IRC
 Investor Relations Contact - -
Xiao Yun Feng PRN
 Corporate Officer/Principal 55 07/12/99
Guo Lin Chai PRN
 Corporate Officer/Principal 57 07/12/99

Members of the board

Members of the board TitleAgeSince
Guo Xian Bao BRD
 Director/Board Member 69 11/05/22
Xin Min Zhao BRD
 Director/Board Member 54 01/01/20
Guo Lin Chai PRN
 Corporate Officer/Principal 57 07/12/99
Wen Bo Su CHM
 Chairman 58 07/05/14
Zhi Jun Liu BRD
 Director/Board Member 52 11/04/16
Ai Guo Shi CEO
 Chief Executive Officer 60 29/06/17
Feng Ming Long BRD
 Director/Board Member 56 01/01/20
Ying Chun Wang BRD
 Director/Board Member 47 01/01/20
Li Jun Wu BRD
 Director/Board Member 50 31/10/91
Yun Jie Wang BRD
 Director/Board Member 46 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 510,657,000 173,807,625 ( 34.04 %) 0 34.04 %

Shareholders

NameEquities%Valuation
Lanzhou State-Owned Assets Supervision & Admin Commission
61.63 %
314,713,676 61.63 % 350 M ¥
Hai Jun Lu
1.743 %
8,900,531 1.743 % 10 M ¥
INDUSTRIAL AND COMMERCIAL BANK OF CHINA LIMITED
1.498 %
7,650,775 1.498 % 9 M ¥
Zhong Ou Asset Management Co., Ltd
1.498 %
7,650,775 1.498 % 9 M ¥
Shi Hui Chen
1.212 %
6,191,300 1.212 % 7 M ¥
Kuwait Investment Authority (Investment Management)
0.6993 %
3,571,120 0.6993 % 4 M ¥
Mu Ping Zheng
0.6071 %
3,100,400 0.6071 % 3 M ¥
Peng Yun Xu
0.4848 %
2,475,900 0.4848 % 3 M ¥
Jian Min Gao
0.4700 %
2,400,000 0.4700 % 3 M ¥
RBC Global Asset Management (Asia) Ltd.
0.3946 %
2,015,200 0.3946 % 2 M ¥

Company contact information

Lanzhou Foci Pharmaceutical Co., Ltd.

2289 Huashan Road Lanzhou New District

730000, Lanzhou

+86 93 1362 889

http://www.fczy.com
address LanZhou Foci Pharmaceutical Co.,Ltd.(002644)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Alternative Medicine

Sales per Business

Sales per region

Sector Alternative Medicine

1st Jan change Capi.
LANZHOU FOCI PHARMACEUTICAL CO.,LTD. Stock LanZhou Foci Pharmaceutical Co.,Ltd.
-18.97% 549M
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+43.35% 6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-15.99% 4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-6.35% 3.19B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+4.87% 3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-0.53% 2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+53.07% 1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-3.63% 1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
+2.76% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.02% 1.6B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 002644 Stock
  4. Company LanZhou Foci Pharmaceutical Co.,Ltd.